Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines (Moderna and Pfizer-BioNTech) and a protein subunit vaccine (Novavax; now manufactured by Sanofi US Inc).
A 2026-2027 COVID-19 vaccine is recommended for all adults ages 18 years and older.
A 2026-2027 COVID-19 vaccine is also recommended for all children ages 6 months–17 years with moderate to severe immunocompromise; for all other children in this age group, a COVID-19 vaccine is recommended through shared clinical decision-making.
This is a test of the website popup tool to let our patients know if there are delays or closures due to inclement weather.
